|Articles|September 3, 2021
Pharmacy Clinical Pearl of the Day: Hypokalemia and Hyperkalemia
Author(s)Saro Arakelians, PharmD
Kidney disease is among the most common causes of both hyperkalemia and hypokalemia.
Advertisement
Clinical Pearl of the Day: Hypokalemia and Hyperkalemia
- Hyperkalemia is high potassium levels.
- Hypokalemia is low potassium levels.
Explanation:
- Normal potassium levels in the body: 3.6- 5.2 (mmol/L).
- Most common causes of hyperkalemia include acute and chronic kidney disease, as well as medications.
- Most common causes of hypokalemia include medication use, such as water pills and kidney disease, as well as alcohol consumption.
- Hyperkalemia treatment options: Patiromer (Veltassa), sodium zirconium (Lokelma)
- Hypokalemia treatment options: Klor-Con, K-Tab, potassium chloride
Reference:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
3
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
4
FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab
5